Avanos Medical Inc. Stock News

Two top Bayer Consumer Health executives are taking on new responsibilities due to strategic moves the business is making in its executive team to str

The Global Enteral Feeding Devices Market 2020-2024 will grow by USD 1.07 bn during 2020-2024

Avanos Medical Inc (NYSE:AVNS) was the target of a significant decline in short interest during the month of May. As of May 29th, there was short interest totalling 2,370,000 shares, a decline of 13.8

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Q1 2020 Avanos Medical Inc Earnings Call

Interest in food as medicine grows as consumers suffering from lower digestive health issues opt for prevention over treatment.

Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June:

Global Helicobacter Pylori Testing Market Insights, Forecast to 2025 May 26, 2020 (Market Insight Reports) -- Helicobacter Pylori Testing Market report will...

Q1 2020 Avanos Medical Inc Earnings Call

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

The enteral syringe market size has the potential to grow by USD 196.72 million during 2020-2024

The

Avanos Medical, Inc. (NYSE:AVNS) Q1 2020 Earnings Conference Call May 06, 2020, 09:00 AM ET Company Participants Dave Crawford - Vice President of Investor Rela

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

Wall Street securities analysts on Thursday revised their ratings and price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge Technologies. HIGH